Peroxisome Proliferator-activated Receptor-gamma Inhibits Transformed Growth of Non-small Cell Lung Cancer Cells Through Selective Suppression of Snail

Overview

Journal Neoplasia

Publisher Elsevier

Specialty Oncology

Date 2010 Mar 18

PMID 20234816

Citations 22

Authors

Rashmi Choudhary

Howard Li

Robert A Winn

Amber L Sorenson

Mary C M Weiser-Evans

Raphael A Nemenoff

Affiliations

Soon will be listed here.

Abstract

Work from our laboratory and others has demonstrated that activation of the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibits transformed growth of non-small cell lung cancer (NSCLC) cell lines in vitro and in vivo. We have demonstrated that activation of PPARgamma promotes epithelial differentiation of NSCLC by increasing expression of E-cadherin, as well as inhibiting expression of COX-2 and nuclear factor-kappaB. The Snail family of transcription factors, which includes Snail (Snail1), Slug (Snail2), and ZEB1, is an important regulator of epithelial-mesenchymal transition, as well as cell survival. The goal of this study was to determine whether the biological responses to rosiglitazone, a member of the thiazolidinedione family of PPARgamma activators, are mediated through the regulation of Snail family members. Our results indicate that, in two independent NSCLC cell lines, rosiglitazone specifically decreased expression of Snail, with no significant effect on either Slug or ZEB1. Suppression of Snail using short hairpin RNA silencing mimicked the effects of PPARgamma activation, in inhibiting anchorage-independent growth, promoting acinar formation in three-dimensional culture, and inhibiting invasiveness. This was associated with the increased expression of E-cadherin and decreased expression of COX-2 and matrix metaloproteinases. Conversely, overexpression of Snail blocked the biological responses to rosiglitazone, increasing anchorage-independent growth, invasiveness, and promoting epithelial-mesenchymal transition. The suppression of Snail expression by rosiglitazone seemed to be independent of GSK-3 signaling but was rather mediated through suppression of extracellular signal-regulated kinase activity. These findings suggest that selective regulation of Snail may be critical in mediating the antitumorigenic effects of PPARgamma activators.

Citing Articles

SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis.

E H, Zhang L, Yang Z, Xu L, Wang T, Guo J J Exp Clin Cancer Res. 2024; 43(1):324.

PMID: 39702326 PMC: 11657537. DOI: 10.1186/s13046-024-03243-0.

Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.

BharathwajChetty B, Sajeev A, Vishwa R, Aswani B, AlQahtani M, Abbas M Cancer Metastasis Rev. 2024; 43(1):321-362.

PMID: 38517618 DOI: 10.1007/s10555-024-10171-0.

PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges.

Zhang J, Tang M, Shang J Biomolecules. 2024; 14(2).

PMID: 38397426 PMC: 10886696. DOI: 10.3390/biom14020190.

The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice.

Li X, Ning L, Ma J, Xie Z, Zhao X, Wang G Cell Commun Signal. 2019; 17(1):136.

PMID: 31655621 PMC: 6815399. DOI: 10.1186/s12964-019-0442-3.

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.

Kleczko E, Kwak J, Schenk E, Nemenoff R Front Immunol. 2019; 10:954.

PMID: 31134065 PMC: 6522855. DOI: 10.3389/fimmu.2019.00954.

References

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

Olmeda D, Jorda M, Peinado H, Fabra A, Cano A . Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene. 2006; 26(13):1862-74. DOI: 10.1038/sj.onc.1209997. View

Bren-Mattison Y, Meyer A, Van Putten V, Li H, Kuhn K, Stearman R . Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB. Mol Pharmacol. 2007; 73(3):709-17. DOI: 10.1124/mol.107.042002. View

Chen D, Jin G, Wang Y, Wang H, Liu H, Liu Y . Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population. Carcinogenesis. 2008; 29(2):342-50. DOI: 10.1093/carcin/bgm285. View

Roman J . Peroxisome proliferator-activated receptor gamma and lung cancer biology: implications for therapy. J Investig Med. 2008; 56(2):528-33. DOI: 10.2310/JIM.0b013e3181659932. View

Tontonoz P, Spiegelman B . Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008; 77:289-312. DOI: 10.1146/annurev.biochem.77.061307.091829. View

Zhuo W, Wang Y, Zhuo X, Zhang Y, Ao X, Chen Z . Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. Lung Cancer. 2008; 62(1):8-14. DOI: 10.1016/j.lungcan.2008.02.007. View

Clarhaut J, Gemmill R, Potiron V, Ait-Si-Ali S, Imbert J, Drabkin H . ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia. 2009; 11(2):157-66. PMC: 2631140. DOI: 10.1593/neo.81074. View

Kumei S, Motomura W, Yoshizaki T, Takakusaki K, Okumura T . Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009; 380(3):614-9. DOI: 10.1016/j.bbrc.2009.01.134. View

10.

Polyak K, Weinberg R . Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9(4):265-73. DOI: 10.1038/nrc2620. View

11.

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View

12.

Smit M, Geiger T, Song J, Gitelman I, Peeper D . A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol. 2009; 29(13):3722-37. PMC: 2698746. DOI: 10.1128/MCB.01164-08. View

13.

Govindarajan R, Ratnasinghe L, Simmons D, Siegel E, Midathada M, Kim L . Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol. 2007; 25(12):1476-81. DOI: 10.1200/JCO.2006.07.2777. View

14.

Cano A, Perez-Moreno M, Rodrigo I, Locascio A, Blanco M, del Barrio M . The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2(2):76-83. DOI: 10.1038/35000025. View

15.

Subbaramaiah K, Lin D, Hart J, Dannenberg A . Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. J Biol Chem. 2001; 276(15):12440-8. DOI: 10.1074/jbc.M007237200. View

16.

Bernhard E, Muschel R . Ras, metastasis, and matrix metalloproteinase 9. Methods Enzymol. 2001; 333:96-104. DOI: 10.1016/s0076-6879(01)33048-3. View

17.

Carver E, Jiang R, Lan Y, Oram K, Gridley T . The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol. 2001; 21(23):8184-8. PMC: 99982. DOI: 10.1128/MCB.21.23.8184-8188.2001. View

18.

Sasaki H, Tanahashi M, Yukiue H, Moiriyama S, Kobayashi Y, Nakashima Y . Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer. Lung Cancer. 2002; 36(1):71-6. DOI: 10.1016/s0169-5002(01)00449-4. View

19.

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

20.

Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K . T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities. J Biol Chem. 2002; 277(22):19649-57. DOI: 10.1074/jbc.M200743200. View